Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Creative Medical Technology Holdings, Inc. (CELZ) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Creative Medical Technology Holdings, Inc. (CELZ), most recent 12 months reported: revenue $3K, net loss $6.04M. Latest balance sheet on file: liquid cash $125K. From SEC filings. Others in Biological Products, (No Diagnostic Substances): VivoSim Labs, Inc. · AIM ImmunoTech Inc. · INMUNE BIO INC. · Senti Biosciences Holdings, Inc. · Acumen Pharmaceuticals, Inc. · Abpro Holdings, Inc. · AGENTIX CORP. · Allogene Therapeutics, Inc.

Stock screener

Watchlist